GlassScriptPhysician profile
Howard M Fillit
NPI 1689770141
$41,533.52
in general payments reported to CMS, 2019-2025
8 companies · $14.63 in 2025
The $14.63 reported for 2025 was less than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $22K · 2021: $2,264 · 2022: $1,721 · 2025: $14.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $14.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $14.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, INC. | $24,375.41 | 2019-2021 | |
| Genentech USA, INC. | $9,811.20 | 2019-2022 | |
| Biogen, INC. | $4,116.00 | 2020 | |
| F. Hoffmann-La Roche Ag | $1,750.86 | 2019 | |
| Pfizer INC. | $771.71 | 2019 | |
| Eli Lilly and Company | $614.15 | 2021-2022 | |
| Abbvie INC. | $79.56 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $14.63 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Fillit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.